Trang chủ

Amikacin Sulfate

Amikacin Sulfate

Thông số

39831-55-5Số CAS
254-648-6Số EC
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;sulfuric acidTên IUPAC
C22H47N5O21S2Công thức hóa học
781.8 g/molKhối lượng phân tử
AMIKACIN SULFATE; 39831-55-5; Arikayce; Amikacin sulphate; BB-K8; Amikacin (as sulfate); Amikacini sulfas; N6M33094FD; NSC-755846; CHEBI:2638; AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER; AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER; DTXSID601045247; Amiglyde-V; NSC177001; Amiglyde; Arikayce Kit; Sulfate, Amikacin; AmiMax E Solution; BBK8; RefChem:915679; BB K8; BBK 8; BB K 8; DTXCID001527174; Amikacin Sulfate Injection, 500 mg/2ml; 3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-1-N-((2S)-4-amino-2-hydroxybutanoyl)-2-deoxy-D-streptamine disulfate; Amikacin disulfate; Amikin; Pierami; Amikacin bis(sulphate); Kaminax; amikacin disulphate; Amikacin (disulfate); Amikacin disulfate salt; MFCD00167475; Amikacin sulfate salt(1:2); (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide disulfate salt; Amikafur; Amitrex; Biodacyn; Chemacin; Fabianol; Likacin; Biklin; C22H47N5O21S2; Kancin-Gap; Antibiotic BB-K8 sulfate; (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide disulfate; O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine sulfate (1:2); NN-K 8; (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;sulfuric acid; EINECS 254-648-6; Amikan; UNII-N6M33094FD; Amikacin sulfate [USAN:USP:JAN]; Amikacin sulfate; 6-O-(3-Amino-3-deoxy-a-d-glucopyranosyl)-4-O-(6-amino-6-deoxy-a-d-glucopyranosyl)-1-N-[(2S)-4-amino-2-hydroxybutanoyl]-2-deoxy-d-streptamine sulfate; Amikin (TN); Amikacin sulfate CRS; (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide;sulfuric acid; AMIKACIN SULFATE [MI]; AMIKACIN SULFATE [JAN]; Amikacin sulfate (JP18/USP); HY-B0509BR; orb1300817; orb1940985; SCHEMBL1649432; AMIKACIN SULFATE [USAN]; AMIKACIN SULFATE [VANDF]; CHEMBL4208954; Amikacin (disulfate) (Standard); HY-B0509B; AMIKACIN SULFATE [MART.]; AMIKACIN SULFATE [USP-RS]; AMIKACIN SULFATE [WHO-DD]; AMIKACINI SULFAS [WHO-IP]; FXKSEJFHKVNEFI-GCZBSULCSA-N; GLXC-23126; Amikacin for system suitability CRS; AMIKACIN SULFATE [GREEN BOOK]; AKOS025310105; AMIKACIN SULFATE [EP IMPURITY]; AMIKACIN SULFATE [ORANGE BOOK]; AA17356; AMIKACIN SULFATE [EP MONOGRAPH]; CCG-270466; CS-3493; NSC 755846; AMIKACIN SULFATE [USP MONOGRAPH]; AS-13777; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, sulfate (1:2)(salt); O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine sulfate (1:2); A2281; NS00088998; T6382; D00865; Q27105754; Amikacin sulfate, European Pharmacopoeia (EP) Reference Standard; Amikacin disulfate salt, potency: 674-786 mug per mg (as amikacin base); Amikacin sulfate, United States Pharmacopeia (USP) Reference Standard; Amikacin for system suitability, European Pharmacopoeia (EP) Reference Standard; Amikacin Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material; (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide bis(sulfate); D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-N(SUP 1)-(4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-, (S)-, SULFATE (1:2) (SALT); D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-N(SUP 1)-(4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-, (S)-, SULPHATE (1:2) (SALT); D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.4))-N1-((2S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, sulfate (1:2) (salt); O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE SULFATE (1:2); O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE SULPHATE (1:2)Tên gọi khác